Literature DB >> 17283238

Altered proinsulin conversion in rat pancreatic islets exposed long-term to various glucose concentrations or interleukin-1beta.

Andreas Börjesson1, Carina Carlsson.   

Abstract

In order to elucidate a possible relationship between beta-cell function and conversion of proinsulin to insulin, isolated rat pancreatic islets were maintained in tissue culture for 1 week at various glucose concentrations (5 x 6-56 mM). Studies were also conducted on islets cultured for 48 h with interleukin-1beta (IL-1beta). By pulse-chase labelling and immunoprecipitation, the relative contents of newly synthesized proinsulin and insulin were determined. ELISA was used to analyse insulin and proinsulin content in medium and within islets. Using real-time PCR, the mRNA levels of proinsulin converting enzymes (PC1 and PC2) were studied. Islets cultured at 56 mM glucose had an increased proportion of newly synthesized proinsulin when compared with islets cultured at 5 x 6 mM glucose after a 90-min chase periods, however, no difference was observed after culture at 11 and 28 mM glucose. ELISA measurements revealed that culture at increased glucose concentrations as well as islet exposure to IL-1beta increased proinsulin accumulation in the culture media. The mRNA expression of PC1 was increased after culture at 11 and 28 mM glucose. Treatment for 48 h with IL-1beta increased the proportion of proinsulin both at 45 and 90 min when compared with control islets. These islets also displayed a decreased mRNA level of PC1 as well as PC2. Calculations of the half-time for proinsulin demonstrated a significant prolongation after treatment with IL-1beta. We conclude that a sustained functional stimulation by glucose of islets is coupled to a decreased conversion of proinsulin which is also true for islets treated with IL-1beta. This may contribute to the elevated levels of proinsulin found both at the onset of type 1 diabetes as well as in type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17283238     DOI: 10.1677/joe.1.06676

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  8 in total

1.  Inhibition of gamma-secretase activity promotes differentiation of embryonic pancreatic precursor cells into functional islet-like clusters in poly(ethylene glycol) hydrogel culture.

Authors:  Mariah N Mason; Melissa J Mahoney
Journal:  Tissue Eng Part A       Date:  2010-08       Impact factor: 3.845

2.  IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat.

Authors:  J A Ehses; G Lacraz; M-H Giroix; F Schmidlin; J Coulaud; N Kassis; J-C Irminger; M Kergoat; B Portha; F Homo-Delarche; M Y Donath
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-30       Impact factor: 11.205

3.  Interferon alpha impairs insulin production in human beta cells via endoplasmic reticulum stress.

Authors:  Angela Lombardi; Yaron Tomer
Journal:  J Autoimmun       Date:  2017-02-24       Impact factor: 7.094

4.  Defective secretion of islet hormones in chromogranin-B deficient mice.

Authors:  Stefanie Obermüller; Federico Calegari; Angus King; Anders Lindqvist; Ingmar Lundquist; Albert Salehi; Maura Francolini; Patrizia Rosa; Patrik Rorsman; Wieland B Huttner; Sebastian Barg
Journal:  PLoS One       Date:  2010-01-28       Impact factor: 3.240

5.  Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity.

Authors:  O Osborn; S E Brownell; M Sanchez-Alavez; D Salomon; H Gram; T Bartfai
Journal:  Cytokine       Date:  2008-08-23       Impact factor: 3.861

6.  Effects of IL-1β-Blocking Therapies in Type 2 Diabetes Mellitus: A Quantitative Systems Pharmacology Modeling Approach to Explore Underlying Mechanisms.

Authors:  R Palmér; E Nyman; M Penney; A Marley; G Cedersund; B Agoram
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-06-11

7.  Islet endothelial activation and oxidative stress gene expression is reduced by IL-1Ra treatment in the type 2 diabetic GK rat.

Authors:  Grégory Lacraz; Marie-Hélène Giroix; Nadim Kassis; Josiane Coulaud; Anne Galinier; Christophe Noll; Mélanie Cornut; Fabien Schmidlin; Jean-Louis Paul; Nathalie Janel; Jean-Claude Irminger; Micheline Kergoat; Bernard Portha; Marc Y Donath; Jan A Ehses; Françoise Homo-Delarche
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

8.  Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies.

Authors:  Campbell Howard; Adele Noe; Andrej Skerjanec; Björn Holzhauer; Margaret Wernsing; Monica Ligueros-Saylan; Tom Thuren
Journal:  Cardiovasc Diabetol       Date:  2014-05-17       Impact factor: 9.951

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.